• NBC5 Features Jacobs in AI Story
    July 16, 2024 by Lucy Gardner Carson
    (JULY 16, 2024) Alicia Jacobs, M.D., associate professor of family medicine and a family care physician at the UVM Health Network, was interviewed by NBC5 about the expanding use of AI across the University of Vermont Health Network to help doctors avoid burnout.
    Read full story at NBC5
  • Collaboration Between Carr and Frietze Leads to Prestigious Department of Defense Impact Award
    June 11, 2024 by Katelyn Queen, PhD
    UVM Cancer Center members Frances Carr, Ph.D., professor of pharmacology, and Seth Frietze, Ph.D., associate professor of biochemistry, have received an Impact Award from the Department of Defense that will allow them to continue their foundational and translational research investigating novel therapeutic strategies for thyroid cancer, the most common endocrine cancer worldwide.
  • Gilbert Comments in Yahoo Finance News Article on Weight-Loss Drugs
    July 10, 2024 by Lucy Gardner Carson
    (JULY 10, 2024) Endocrinologist Matthew Gilbert, D.O., M.P.H., professor of medicine, commented for a story in Yahoo Finance News on whether or not weight-loss drugs can be used as a temporary “metabolic reset.”
    Read full story at Yahoo Finance News
  • SNMA Partners with Richard Kemp Center to Support Community Wellness
    July 4, 2024 by Margie Brenner
    Larner’s Student National Medical Association partnered with the Richard Kemp Center in Burlington recently to host “Ubuntu: Nurturing Community Wellness.” The evening of health-focused activities and celebration, including workshops on mental health, personal development, and more, truly exemplified Ubuntu—an ancient African word expressing the interconnectedness between people.
  • Jacobs, Sanders Quoted in Healthcare Finance News Report on AI Clinical Documentation Partnership
    July 9, 2024 by Lucy Gardner Carson
    (JULY 9, 2024) Alicia Jacobs, M.D., associate professor of family medicine, and Jason Sanders, M.D., M.B.A., president and CEO of the UVM Medical Group, commented to Healthcare Finance News for a story about a new partnership between the University of Vermont Health Network and Abridge to use AI for clinical documentation.
    Read full story at Healthcare Finance
  • Health Heroes Community Workshops Bring Hands-On Learning to Youth
    July 3, 2024 by Margie Brenner
    This spring, thanks to a collaboration between the UVM Larner College of Medicine and UVM Extension 4-H, Health Heroes Community Workshops for Youth offered three hands-on learning sessions to more than 25 local eighth- to 12th-graders interested in health and health care. The partnership extends the reach of Larner to five local counties, advancing steps toward a healthier Vermont.
  • Rohit Singh, MD, Contributes to Our Understanding of Palliative Care Utilization
    July 3, 2024 by Katelyn Queen, PhD
  • VT Digger Reports Eappen Comments on Vt. Participation in AHEAD Model
    July 3, 2024 by Lucy Gardner Carson
    (JULY 3, 2024) Sunil (“Sunny”) Eappen, M.D., M.B.A., president and CEO of the University of Vermont Health Network and clinical professor of anesthesiology at the Larner College of Medicine, commented in a VTDigger article on the selection of Vermont to take part in a federal health care reform model known as AHEAD.
    Read full story at VTDigger
  • Medical Students Selected as 2024-25 Schweitzer Fellows
    July 2, 2024 by John Turner
    5 teams of UVM Larner College of Medicine Class of 2027 medical students, along with 5 teams from Geisel School of Medicine at Dartmouth College, and Vermont Law and Graduate School, have been selected to participate as 2024–25 Schweitzer Fellows through the New Hampshire/Vermont (NH/VT) Schweitzer Fellows Program.
  • Inaugural Award will Accelerate Cancer Clinical Trials
    July 1, 2024 by Kate Strotmeyer
  • From Bench to Bedside: Positive Data from a Phase 1 Clinical Trial of RSO-021
    June 17, 2024 by Kate Strotmeyer
    Using a novel therapy discovered in the Cunniff Lab at the University of Vermont Cancer Center, RS Oncology, a privately held biopharmaceutical company focusing on novel treatments for rare and aggressive cancers, presented positive results from its Phase 1 study in patients with Malignant Pleural Mesothelioma (MPM) with Malignant Pleural Effusion (MPE) or MPE associated with other solid tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
  • Bridging Gaps in Immunity: Research Links Gut Health to Vaccine Resistance
    June 28, 2024 by Janet Essman Franz
    Undernourished children are more vulnerable to pathogens and more likely to die from vaccine-preventable infectious disease, even when vaccinated. Research by Benjamin Lee, M.D., associate professor of pediatrics, points to gut health as a contributing factor.
  • Medical Students’ Project Improves Rural Health Care Access
    June 28, 2024 by Janet Essman Franz
    A Gold Foundation fellowship project by Lindsay Aldrich ’25 and Richard Vuong ’25 has led to an innovative new health care delivery vehicle and a novel technology agreement between UVM’s biomedical engineering design hub and the UVM Health Network. The project aims to bring the doctor’s office to people living in Vermont’s rural regions.
  • Connections Matter: Collaborative Study Stems from Department of Pathology and Laboratory Medicine Annual Research Day
    June 28, 2024 by Katelyn Queen, PhD
  • Hebert Runs 93-mile Rail Trail in Honor of Late Wife, WCAX Reports
    June 25, 2024 by Lucy Gardner Carson
    (JUNE 25, 2024) Christopher Hebert, M.D.’02, clinical instructor of medicine, ran the entire length of the 93-mile Lamoille Valley Rail Trail in honor of late wife, Lisa, who died this past February after a four-year battle with ovarian cancer, WCAX-TV reported.
    Read full story at WCAX-TV
  • Rutland Herald Reports Aslakson, Pierce Named to Executive Leadership Program
    June 25, 2024 by Lucy Gardner Carson
    (JUNE 25, 2024) Rebecca Aslakson, M.D., Ph.D., professor and chair of anesthesiology, and Kristen Pierce, M.D., professor of medicine, have been selected as fellows in the 2024–25 Hedwig van Ameringen Executive Leadership in Academic Medicine Program, according to the Rutland Herald.
    Read full story at the Rutland Herald
  • Culinary Medicine Course Selected for 2024 Frymoyer Scholars Program
    June 20, 2024 by Janet Essman Franz
    Medical students Molly Hurd and Sarah Krumholz, and Alyssa Tenney, Aassistant Professor of Family Medicine Whitney Calkins, M.D., and chef educator Christina Vollbrecht were selected as 2024 Frymoyer Scholars. The scholarship supports development of a culinary medicine course that provides future doctors with skills and confidence to discuss nutrition and food access in patient care settings.
  • Aslakson and Pierce Selected for Executive Leadership in Academic Medicine Fellowship
    June 20, 2024 by Janet Essman Franz
    Larner College of Medicine professors Rebecca Aslakson, M.D., Ph.D., and Kristen Pierce, M.D., have been selected to participate in a prestigious fellowship that prepares senior women faculty at schools of medicine for institutional leadership positions. They join a class of 98 fellows in the 2024–25 Hedwig van Ameringen Executive Leadership in Academic Medicine® fellowship.
  • Ehret Selected for 2024–25 Class of Executive Leadership in Health Care Fellows
    June 18, 2024 by Janet Essman Franz
    Danielle Ehret, M.D., M.P.H., associate professor of pediatrics, has been selected as a member of the 2024–25 class of fellows in the Executive Leadership in Health Care (ELH) program. The prestigious fellowship provides funding, sponsorship, and protected time to support the fellow’s advancement and opportunities for increased responsibility to bring their full potential to health care organizations. Candidates aspire to lead at the executive level, such as a chief officer. Ehret serves chief medical officer for the Vermont Oxford Network.
  • New Study Introduces Novel Methodology to Benchmark Hospitals on In-Hospital Disparities
    June 18, 2024 by Katelyn Queen, PhD